Zimmer Biomet Holdings Inc (ZBH)
NYSE · Healthcare · Medical Devices
Zimmer Biomet Holdings Inc is a Healthcare company with a market capitalization of $18.01B, a trailing P/E ratio of 24.1, and a dividend yield of 1.06%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 28, 2026 | $2.09 | $1.86 | +12.4% |
| Q4 2025 | February 10, 2026 | $2.42 | $2.40 | +0.8% |
| Q3 2025 | November 5, 2025 | $1.16 | $0.93 | +24.7% |
| Q2 2025 | August 7, 2025 | $0.77 | $1.18 | -34.8% |
| Q1 2025 | May 5, 2025 | $0.91 | $0.87 | +4.6% |
| Q4 2024 | February 6, 2025 | $2.31 | $2.29 | +0.9% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Zimmer Biomet Holdings Inc's market cap?
As of June 29, 2026, Zimmer Biomet Holdings Inc (ZBH) has a market capitalization of $18.01B.
What is Zimmer Biomet Holdings Inc's P/E ratio?
Zimmer Biomet Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 24.1. Its forward P/E is 11.2.
Does Zimmer Biomet Holdings Inc pay a dividend?
Yes — Zimmer Biomet Holdings Inc pays a dividend yielding 1.06%, an annual payout of $0.96 per share.
What sector is ZBH in?
Zimmer Biomet Holdings Inc is in the Healthcare sector, specifically the Medical Devices industry.
What was Zimmer Biomet Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Zimmer Biomet Holdings Inc reported revenue of $8.23B and net income of $705.20M.
Ask your own questions about ZBH
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.